These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 10094115

  • 1. Urinary excretion of apolipoprotein(a) fragments in type 1 diabetes mellitus patients.
    Clodi M, Oberbauer R, Bodlaj G, Hofmann J, Maurer G, Kostner K.
    Metabolism; 1999 Mar; 48(3):369-72. PubMed ID: 10094115
    [Abstract] [Full Text] [Related]

  • 2. Urinary excretion of apo(a) fragments in NIDDM patients.
    Clodi M, Oberbauer R, Waldhäusl W, Maurer G, Kostner GM, Kostner K.
    Diabetologia; 1997 Dec; 40(12):1455-60. PubMed ID: 9447954
    [Abstract] [Full Text] [Related]

  • 3. Decreased urinary apolipoprotein (a) excretion in patients with impaired renal function.
    Kostner KM, Clodi M, Bodlaj G, Watschinger B, Hörl W, Derfler K, Huber K.
    Eur J Clin Invest; 1998 Jun; 28(6):447-52. PubMed ID: 9693935
    [Abstract] [Full Text] [Related]

  • 4. Urinary apo(a) discriminates coronary artery disease patients from controls.
    Kostner KM, Huber K, Stefenelli T, Rinner H, Maurer G.
    Atherosclerosis; 1997 Feb 28; 129(1):103-10. PubMed ID: 9069524
    [Abstract] [Full Text] [Related]

  • 5. Lipoprotein(a) in type 1 diabetic patients with renal disease.
    Groop PH, Viberti GC, Elliott TG, Friedman R, Mackie A, Ehnholm C, Jauhiainen M, Taskinen MR.
    Diabet Med; 1994 Dec 28; 11(10):961-7. PubMed ID: 7895461
    [Abstract] [Full Text] [Related]

  • 6. Molecular analysis of apo(a) fragmentation in polygenic hypercholesterolemia: characterization of a new plasma fragment pattern.
    Gonbert S, Saint-Jore B, Giral P, Doucet C, Chapman J, Thillet J.
    Arterioscler Thromb Vasc Biol; 2001 Aug 28; 21(8):1353-8. PubMed ID: 11498465
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Lipoprotein(a) levels and apolipoprotein(a) polymorphism in type 1 diabetes mellitus: relationships to microvascular and neurological complications.
    Gazzaruso C, Garzaniti A, Buscaglia P, D'Annunzio G, Porta A, Vandelli G, Lorini R, Finardi G, Fratino P, Geroldi D.
    Acta Diabetol; 1998 Apr 28; 35(1):13-8. PubMed ID: 9625284
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Apolipoprotein(a) in insulin-dependent diabetic patients with and without diabetic nephropathy.
    Gall MA, Rossing P, Hommel E, Voldsgaard AI, Andersen P, Nielsen FS, Dyerberg J, Parving HH.
    Scand J Clin Lab Invest; 1992 Oct 28; 52(6):513-21. PubMed ID: 1411263
    [Abstract] [Full Text] [Related]

  • 13. Elevated plasma lipoprotein(a) in patients with the nephrotic syndrome.
    Wanner C, Rader D, Bartens W, Krämer J, Brewer HB, Schollmeyer P, Wieland H.
    Ann Intern Med; 1993 Aug 15; 119(4):263-9. PubMed ID: 8328733
    [Abstract] [Full Text] [Related]

  • 14. Urinary apolipoprotein (a) excretion in patients with proteinuria.
    Kostner KM, Banyai S, Banyai M, Bodlaj G, Maurer G, Derfler K, Hörl WH, Oberbauer R.
    Ann Med; 1998 Oct 15; 30(5):497-502. PubMed ID: 9814837
    [Abstract] [Full Text] [Related]

  • 15. Relationship of non-LDL-bound apo(a), urinary apo(a) fragments and plasma Lp(a) in patients with impaired renal function.
    Cauza E, Kletzmaier J, Bodlaj G, Dunky A, Herrmann W, Kostner K.
    Nephrol Dial Transplant; 2003 Aug 15; 18(8):1568-72. PubMed ID: 12897096
    [Abstract] [Full Text] [Related]

  • 16. LDL-apheresis significantly reduces urinary apo(a) excretion.
    Kostner KM, Jansen M, Maurer G, Derfler K.
    Eur J Clin Invest; 1997 Jan 15; 27(1):93-5. PubMed ID: 9041383
    [Abstract] [Full Text] [Related]

  • 17. Renal disease as a determinant of increased lipoprotein(a) concentrations in diabetic patients.
    Boemi M, Sirolla C, Fumelli P, James RW.
    Diabetes Care; 1999 Dec 15; 22(12):2033-6. PubMed ID: 10587838
    [Abstract] [Full Text] [Related]

  • 18. Increased secretion of TGF-beta1 by peripheral blood mononuclear cells from patients with Type 1 diabetes mellitus with diabetic nephropathy.
    Korpinen E, Groop PH, Fagerudd JA, Teppo AM, Akerblom HK, Vaarala O.
    Diabet Med; 2001 Feb 15; 18(2):121-5. PubMed ID: 11251675
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Increased plasma apolipoprotein (a) levels in IDDM patients with diabetic nephropathy.
    Tarnow L, Rossing P, Nielsen FS, Hansen BV, Dyerberg J, Parving HH.
    Diabetes Care; 1996 Dec 15; 19(12):1382-7. PubMed ID: 8941468
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.